The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders
Open accessAbstract
Autism Genes, Again and Again: Despite recent advances in sequencing technologies and their lowered costs—effective, highly sensitive, and specific sequencing of multiple genes of interest from large cohorts remains expensive. O'Roak et al. (p. 1619 ; published online 15 November) modified molecular inversion probe methods for target-specific capture and sequencing to resequence candidate genes in thousands of patients. The technique was applied to 44 candidate genes to identify de novo mutations in a large cohort of individuals with and without autism spectrum disorder. The analysis revealed several de novo mutations in genes that together contribute to 1% of sporadic autism spectrum disorders, supporting the notion that multiple genes underlie autism-spectrum disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genes in this subnetwork were evaluated in a larger cohort in a targeted sequencing study120, which identified more risk variants compared with chance and demonstrated that PPI connectivity can be a predictor of ASD risk mutations.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [120]
In the citing paper
“chromodomain helicase DNA-binding protein 8 (CHD8)118, which is the gene most frequently affected by ASD-associated rare de novo variation72,119–121.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [120]
In the citing paper
“Another striking candidate is DYRK1A (dual-specificity tyrosine phosphorylation-regulated kinase 1A), for which three truncating mutations have been discovered in autism probands [24,44] and de novo structural variants in ID probands [54,55].”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [44]
In the citing paper
“Altogether, this assay yielded 27 new de novo mutations across 16 genes; of these mutations, 17 were disruptive SNVs, a fraction higher than expected by chance.”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [44]
In the citing paper
“Overall, eight de novo truncating mutations were observed across 2597 cases in this gene; by contrast, no such mutations were observed in control siblings, or in over 6500 exomes in the ESP.”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [44]
In the citing paper
“The discovery of these mutations confirmed the association with ASD for CHD8 and DYRK1A and provided significant statistical support for four novel genes: GRIN2B (glutamate receptor, ionotropic, N-methyl d-aspartate 2B), TBR1 (T-box brain gene 1), PTEN (phosphatase and tensin homolog), and TBL1XR1 [transducin (beta)-like 1 X-linked receptor 1].”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [44]
In the citing paper
“Strikingly, ASD cases with truncating mutations in CHD8 have significant macrocephaly [44], whereas all three cases with truncating mutations in beta-catenin have microcephaly ([28]; B.J. O’Roak, unpublished).”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [44]
In the citing paper
“the development of low-cost/high-throughput MIP-based resequencing has strongly implicated a half-dozen novel genes accounting for 1% of disease based on a limited survey of 44 genes [44].”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [44]
In the citing paper
“of eight truncating de novo CHD8 mutations in ASD probands, five had ID and three had IQs above 90 [44].”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [44]
In the citing paper
“Under a de novo rate of 1.2 non-synonymous coding variants per individual, we estimate the probability of detecting eight or more de novo truncating events in ADNP within our cohort as p = 2.65e-18 (binomial test).”
From A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP (2014) · cites this paper as [16]
In the citing paper
“De novo loss of function mutations in this gene had previously been identified in two patients by WES2 and targeted resequencing16 of patients with ASD. In those studies however, causal relationship did not reach locus-specific significance.”
From A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP (2014) · cites this paper as [16]
In the citing paper
“An inherited p.Gly1094Profs*5 mutation was identified by MIP sequencing16 but the reported frameshift is the ninth amino acid from the C-terminal end of the protein and not associated with any protein domains.”
From A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP (2014) · cites this paper as [16]
In the citing paper
“Many studies of complex neuropsychiatric disorders have also concluded that disease-causing variants are often clustered in protein-interaction networks with a high degree of connectivity among themselves and that these clustered networks are often enriched with functional pathways relevant to brain functions [72–80].”
From An integrated analysis of genes and functional pathways for aggression in human and rodent models (2019) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A draft sequence of the Neandertal genome
Green, R. E., Krause, J., Briggs, A. W., Maricic, T., Stenzel, U., Kircher, M., Patterson, N., Li, H., Zhai, W., Fritz, M. H.-Y., et al. (2010) · Science · doi:10.1126/science.1188021 · Cited by 4,318
Self-citationSporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
Self-citationRate of de novo mutations and the importance of father’s age to disease risk
Kong, A., Frigge, M. L., Masson, G., Besenbacher, S., Sulem, P., Magnusson, G., Gudjonsson, S. A., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., et al. (2012) · Nature · doi:10.1038/nature11396 · Cited by 2,134
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734
SMART 7: recent updates to the protein domain annotation resource
Letunić, I., Doerks, T., & Bork, P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr931 · Cited by 1,714
Evolution and functional impact of rare coding variation from deep sequencing of human exomes
Tennessen, J. A., Bigham, A. W., O’Connor, T. D., Fu, W., Kenny, E. E., Gravel, S., McGee, S., Do, R., Liu, X., Jun, G., et al. (2012) · Science · doi:10.1126/science.1219240 · Cited by 1,613
Self-citationDe Novo Gene Disruptions in Children on the Autistic Spectrum
Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., Yamrom, B., Lee, Y.-H., Narzisi, G., Leotta, A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.04.009 · Cited by 1,446
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421
Self-citationA copy number variation morbidity map of developmental delay
Cooper, G. M., Coe, B. P., Girirajan, S., Rosenfeld, J. A., Vu, T. H., Baker, C., Williams, C., Stalker, H., Hamid, R., Hannig, V., et al. (2011) · Nature Genetics · doi:10.1038/ng.909 · Cited by 1,351
Self-citation
Cited by
Sorted by citations
Items 101–111 of 111
Pirozzi, F., Berkseth, M., Shear, R., Gonzalez, L., Timms, A. E., Sulc, J., Pao, E., Oyama, N., Forzano, F., Conti, V., et al. (2022) · Brain · doi:10.1093/brain/awab376 · Cited by 54
The clinical presentation caused by truncating CHD8 variants
Douzgou, S., Liang, H. W., Metcalfe, K., Somarathi, S., Tischkowitz, M., Mohamed, W., Kini, U., McKee, S., Yates, L., Bertoli, M., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13554 · Cited by 52
Loss of Adenylyl Cyclase Type-5 in the Dorsal Striatum Produces Autistic-Like Behaviors
Kim, H., Lee, Y., Park, J.-Y., Kim, J.-E., Kim, T.-K., Choi, J., Lee, J.-E., Lee, E.-H., Kim, D., Kim, K.-S., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0256-x · Cited by 50
PSMD12 haploinsufficiency in a neurodevelopmental disorder with autistic features
Khalil, R., Kenny, C., Hill, R. S., Mochida, G. H., Nasir, R., Partlow, J. N., Barry, B. J., Al‐Saffar, M., Egan, C., Stevens, C. R., et al. (2018) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32688 · Cited by 39
Webb, S. J., Garrison, M. M., Bernier, R., McClintic, A. M., King, B. H., & Mourad, P. D. (2017) · Autism Research · doi:10.1002/aur.1690 · Cited by 29
Self-citationChromatin regulators, phenotypic robustness, and autism risk
Suliman, R., Ben-David, E., & Shifman, S. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00081 · Cited by 28
Vardarajan, B. N., Eran, A., Jung, J.-Y., Kunkel, L. M., & Wall, D. P. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.38 · Cited by 26
Molecular subtyping and improved treatment of neurodevelopmental disease
Stessman, H. A. F., Turner, T. N., & Eichler, E. E. (2016) · Genome Medicine · doi:10.1186/s13073-016-0278-z · Cited by 25
Self-citationMozzi, A., Forni, D., Cagliani, R., Pozzoli, U., Clerici, M., & Sironi, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-06440-4 · Cited by 19
The Genetics of Autism Spectrum Disorders
Yuen, R. K. C., Szatmari, P., & Vorstman, J. A. S. (2019) · Autism and Pervasive Developmental Disorders · doi:10.1017/9781108297769.006 · Cited by 19
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Metadata
- Authors
- O’Roak, B. J., Vives, L., Fu, W., Egertson, J. D., Stanaway, I. B., Phelps, I. G., Carvill, G., Kumar, A., Lee, C., Ankenman, K., Munson, J., Hiatt, J. B., Turner, E. H., Levy, R., O’Day, D. R., Krumm, N., Coe, B. P., Martin, B. K., Borenstein, E., Nickerson, D. A., Mefford, H. C., Doherty, D., Akey, J. M., Bernier, R., Eichler, E. E., & Shendure, J.
- Affiliations
- University of Washington (US)
- Seattle Children's Hospital (US)
- Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98195, USA.
- Santa Fe Institute (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Eichler, Evan E.
- Shendure, Jay
- ORCID
- O’Roak, Brian J.
- Egertson, Jarrett D.
- Stanaway, Ian B.
- Carvill, Gemma
- Kumar, Akash
- Lee, Choli
- Ankenman, Katy
- Hiatt, Joseph B.
- Turner, Emily H.
- O’Day, Diana R.
- Krumm, Niklas
- Coe, Bradley P.
- Martin, Beth K.
- Borenstein, Elhanan
- Nickerson, Deborah A.
- Mefford, Heather C.
- Doherty, Dan
- Akey, Joshua M.
- Bernier, Raphael
- Eichler, Evan E.
- Shendure, Jay
- Venue
- Science
- Published
- 2012-12-21
- Volume
- 338
- Issue
- 6114
- Pages
- 1619-1622
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3528801
- OpenAlex
- W1988670106
- Cited by
- 1,240
- References
- 93
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 55 · 2023: 61 · 2022: 85 · 2021: 101 · 2020: 91 · 2019: 111 · 2018: 96 · 2017: 124 · 2016: 124 · 2015: 117 · 2014: 133 · 2013: 78 · 2012: 1
- FWCI
- 53.93
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (1rc2hl103010-01)
- National Heart, Lung, and Blood Institute (HL 102923, RC2HL102925, HL-102924, HL-102925, RC2HL102926, RC2HL102923, UC2HL102924, RC2HL-103010, UC2HL102925, HL 103010, UC2HL102923, UC2HL103010, RC2HL102924, UC2HL102926, HL-102926)
- National Institute of Neurological Disorders and Stroke (R56NS069605, R01NS064077, R01NS069605, NS069605)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD065285, R01HD065285)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- autism spectrum disorder, recurrent mutations, de novo mutations, molecular inversion probes, CHD8, DYRK1A, NR2B subunit, Tbr1, PTEN, TBL1XR1, macrocephaly, microcephaly, β-catenin, chromatin remodeling, gene disruption, splicing disruption
- MeSH terms
- Dyrk Kinases, Cephalometry, Child, Child Development Disorders, Pervasive, Child, Preschool, DNA-Binding Proteins, Female, Humans, Male, Microcephaly, Mutation, Nuclear Proteins, Protein-Tyrosine Kinases, Repressor Proteins, Transcription Factors, Cohort Studies, DNA Probes, Receptors, N-Methyl-D-Aspartate, Protein Serine-Threonine Kinases, Sequence Analysis, DNA, Receptors, Cytoplasmic and Nuclear, Genetic Predisposition to Disease, T-Box Domain Proteins, Chromatin Assembly and Disassembly, PTEN Phosphohydrolase, beta Catenin, Genetic Association Studies, Megalencephaly, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
